ICMR aims to launch indigenous Covid-19 vaccine by August 15
ICMR has asked Bharat Biotech to fast track the clinical trial mechanism and ensure that the subject enrolment is initiated by 7th of July.
This is the first indigenous vaccine being developed in India and one of the top priority projects of the government. The vaccine is derived from a SARS-COV2 strain isolated by ICMR-National Institute of Virology, Pune. ICMR and Bharat Biotech are jointly working for the pre-clinical as well as clinical development of this vaccine.
Recently, the Central Drug Standard Control Organisation, the National regulatory body for Indian Pharmaceuticals and medical devices, has granted approval to Bharat Biotech India to conduct human clinical trials for Corona Vaccine called ‘Covaxin’.